Genedx Holdings Corp Stock Alpha and Beta Analysis
| WGSWW Stock | 0.04 0.01 44.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as GeneDx Holdings Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in GeneDx Holdings over a specified time horizon. Remember, high GeneDx Holdings' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to GeneDx Holdings' market risk premium analysis include:
Beta (3.28) | Alpha (0.25) | Risk 11.99 | Sharpe Ratio (0.04) | Expected Return (0.52) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out GeneDx Holdings Backtesting, GeneDx Holdings Valuation, GeneDx Holdings Correlation, GeneDx Holdings Hype Analysis, GeneDx Holdings Volatility, GeneDx Holdings History and analyze GeneDx Holdings Performance. GeneDx Holdings Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. GeneDx Holdings market risk premium is the additional return an investor will receive from holding GeneDx Holdings long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in GeneDx Holdings. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate GeneDx Holdings' performance over market.| α | -0.25 | β | -3.28 |
GeneDx Holdings expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of GeneDx Holdings' Buy-and-hold return. Our buy-and-hold chart shows how GeneDx Holdings performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.GeneDx Holdings Market Price Analysis
Market price analysis indicators help investors to evaluate how GeneDx Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GeneDx Holdings shares will generate the highest return on investment. By understating and applying GeneDx Holdings stock market price indicators, traders can identify GeneDx Holdings position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Price Ceiling Movement | ||
| Tangent Of Price Series | ||
| Aroon Oscillator | ||
| Aroon Oscillator | ||
| Kaufman Adaptive Moving Average | ||
| Bollinger Bands | ||
| Rickshaw Man | ||
| Harami Cross Pattern |
GeneDx Holdings Return and Market Media
The median price of GeneDx Holdings for the period between Wed, Oct 22, 2025 and Tue, Jan 20, 2026 is 0.062 with a coefficient of variation of 31.07. The daily time series for the period is distributed with a sample standard deviation of 0.02, arithmetic mean of 0.06, and mean deviation of 0.02. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Is GeneDx Holdings Corp. stock a top pick in earnings season - Index Update Community Shared Stock Ideas - newser.com | 11/10/2025 |
2 | Disposition of tradable shares by Ruch Joshua of GeneDx Holdings at 162.0 subject to Rule 16b-3 | 11/24/2025 |
3 | Disposition of 421 shares by Kevin Feeley of GeneDx Holdings at 110.0474 subject to Rule 16b-3 | 11/28/2025 |
4 | Feeley, GeneDx CFO, sells 61,276 in WGS stock By Investing.com - Investing.com India | 12/03/2025 |
5 | GeneDx Holdings Corp. WGS Shares Purchased by Rhumbline Advisers - MarketBeat | 12/08/2025 |
6 | BTIG Maintains GeneDx Holdings Buy Recommendation - Nasdaq | 12/12/2025 |
7 | WGS Wells Fargo Raises Price Target to 155, Maintains Equal-We - GuruFocus | 12/15/2025 |
8 | Why GeneDx Holdings Corp. stock could rally in 2025 - Quarterly Profit Report Accurate Entry and Exit Point Alerts - DonanmHaber | 12/19/2025 |
9 | Canaccord Genuity Group Forecasts Strong Price Appreciation for GeneDx Stock - MarketBeat | 12/22/2025 |
10 | Should GeneDxs GUARDIAN Newborn Genomics Accolade Reshape the Investment Narrative for WGS Investors - simplywall.st | 01/05/2026 |
11 | GeneDx Reports Strong 2025 Results and 2026 Growth Outlook - TipRanks | 01/12/2026 |
12 | Disposition of 554 shares by Katherine Stueland of GeneDx Holdings at 109.1292 subject to Rule 16b-3 | 01/16/2026 |
About GeneDx Holdings Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including GeneDx or other stocks. Alpha measures the amount that position in GeneDx Holdings Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 59.13 | 44.97 | 51.71 | 62.26 | PTB Ratio | 0.29 | 8.43 | 9.69 | 9.21 |
GeneDx Holdings Investors Sentiment
The influence of GeneDx Holdings' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in GeneDx. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to GeneDx Holdings' public news can be used to forecast risks associated with an investment in GeneDx. The trend in average sentiment can be used to explain how an investor holding GeneDx can time the market purely based on public headlines and social activities around GeneDx Holdings Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
GeneDx Holdings' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for GeneDx Holdings' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average GeneDx Holdings' news discussions. The higher the estimated score, the more favorable is the investor's outlook on GeneDx Holdings.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GeneDx Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GeneDx Holdings' short interest history, or implied volatility extrapolated from GeneDx Holdings options trading.
Build Portfolio with GeneDx Holdings
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.